Sanara MedTech Inc. (SMTI) Misses Q2 EPS by 9c, misses on revenue

Sanara MedTech Inc. (NASDAQ: SMTI) reported Q2 EPS of ($0.22), $0.09 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $15.75 million versus the consensus estimate of $16.9 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calamp Corp. (CAMP) Misses Q2 EPS by 33c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c